Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Okunaka

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser]K Furuse, T Okunaka, H Sakai, et al.
Cancer|July 15, 1991
Photodynamic therapy for multiple primary bronchogenic carcinomaT Okunaka, H Kato, C Konaka, et al.
Diagnostic and Therapeutic Endoscopy|January 1, 1997
Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung CancerH Kato, T Okunaka, C Konaka, et al.
The Journal of Urology|October 1, 1992
A new porphyrin photosensitizer (PH1008) in model membranes, normal cells, and bladder cancer cellsM Tolentino, T Okunaka, M L Eckhauser, et al.
Diagnostic and Therapeutic Endoscopy|January 1, 1996
Photodynamic therapy for head and neck cancerT Yoshida, H Kato, T Okunaka, et al.
International Journal of Radiation Biology|July 1, 1995
Photofrin photosensitization. Correlation of Photofrin:erythrocyte binding processes with photolysisK Yamada, H Yamamoto, T Okunaka, et al.
Diagnostic and Therapeutic Endoscopy|May 22, 2008
Early detection of bronchial lesions using lung imaging fluorescence endoscopeN Ikeda, H Honda, T Katsumi, et al.
Lasers in Surgery and Medicine|June 22, 2006
Basic and clinical research on photodynamic therapy at Tokyo Medical University HospitalH Kato, J Usuda, T Okunaka, et al.
Oncology Reports|August 3, 2007
A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivoT Okunaka, J Usuda, S Ichinose, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2007
Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a "never-smoked" female patient with advanced non-small cell lung cancerJ Usuda, T Ohira, Y Suga, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser]K Furuse, T Okunaka, H Sakai, et al.
Cancer|July 15, 1991
Photodynamic therapy for multiple primary bronchogenic carcinomaT Okunaka, H Kato, C Konaka, et al.
Diagnostic and Therapeutic Endoscopy|January 1, 1997
Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung CancerH Kato, T Okunaka, C Konaka, et al.
The Journal of Urology|October 1, 1992
A new porphyrin photosensitizer (PH1008) in model membranes, normal cells, and bladder cancer cellsM Tolentino, T Okunaka, M L Eckhauser, et al.
Diagnostic and Therapeutic Endoscopy|January 1, 1996
Photodynamic therapy for head and neck cancerT Yoshida, H Kato, T Okunaka, et al.
International Journal of Radiation Biology|July 1, 1995
Photofrin photosensitization. Correlation of Photofrin:erythrocyte binding processes with photolysisK Yamada, H Yamamoto, T Okunaka, et al.
Diagnostic and Therapeutic Endoscopy|May 22, 2008
Early detection of bronchial lesions using lung imaging fluorescence endoscopeN Ikeda, H Honda, T Katsumi, et al.
Lasers in Surgery and Medicine|June 22, 2006
Basic and clinical research on photodynamic therapy at Tokyo Medical University HospitalH Kato, J Usuda, T Okunaka, et al.
Oncology Reports|August 3, 2007
A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivoT Okunaka, J Usuda, S Ichinose, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2007
Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a "never-smoked" female patient with advanced non-small cell lung cancerJ Usuda, T Ohira, Y Suga, et al.
Pageof 5